A1G
0.53
68.3%
HWK
0.026
-21.2%
BOC
0.84
37.7%
IBX
0.021
-19.2%
RBRDA
0.015
36.4%
CAN
0.009
-18.2%
EDU
0.815
34.7%
CYQ
0.005
-16.7%
FBR
0.004
33.3%
IPT
0.005
-16.7%
M4M
0.008
33.3%
EE1
0.006
-14.3%
AYT
0.005
25%
G88
0.006
-14.3%
GR8
0.2
25%
OVT
0.006
-14.3%
PGY
0.005
25%
FAL
0.545
-13.5%
RLG
0.005
25%
HYD
0.013
-13.3%
TMX
0.005
25%
DTZ
0.049
-12.5%
WLD
0.016
23.1%
FRX
0.014
-12.5%
YUG
0.064
20.8%
RB6
0.11
-12%
APC
0.012
20%
MVL
0.015
-11.8%
PIQ
0.48
20%
ORP
0.045
-11.8%
VRC
0.006
20%
T92
0.053
-11.7%
RGL
0.007
16.7%
HMX
0.023
-11.5%
8CO
0.029
16%
PNR
4.78
-11.3%
ECT
0.155
14.8%
PVW
0.016
-11.1%
LPM
0.155
14.8%
TNC
0.56
-11.1%
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

AVITA Medical (ASX:AVH) signed an exclusive 5 year distribution agreement with Stedical Scientific

AVITA Medical (ASX:AVH) signed an exclusive five year distribution agreement with Stedical Scientific, to commercialise PermeaDerm® Biosynthetic Wound Matrix in the U.S. The matrix is cleared by the U.S. FDA and used for a variety of injuries | https://announcements.asx.com.au/asxpdf/20240111/pdf/05zbp446ftpyw0.pdf #FDA #PermeaDerm #AVH